Biphenyl compounds useful as muscarinic receptor antagonists

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

08034946

ABSTRACT:
This invention provides compounds of formula I:wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

REFERENCES:
patent: 5618827 (1997-04-01), Oxford
patent: 5658549 (1997-08-01), Akehurst et al.
patent: 5674860 (1997-10-01), Carling et al.
patent: 6617325 (2003-09-01), Lehmann-Lintz et al.
patent: 6635764 (2003-10-01), Mammen et al.
patent: 6656694 (2003-12-01), Mammen
patent: 6693202 (2004-02-01), Aggen et al.
patent: 7141671 (2006-11-01), Mammen et al.
patent: 7262205 (2007-08-01), Mammen et al.
patent: 7265133 (2007-09-01), Mammen et al.
patent: 7288657 (2007-10-01), Mammen et al.
patent: 7345060 (2008-03-01), Mammen et al.
patent: 7456199 (2008-11-01), Mammen et al.
patent: 7479562 (2009-01-01), Ji et al.
patent: 7491736 (2009-02-01), Mammen et al.
patent: 7501442 (2009-03-01), Mammen et al.
patent: 7521041 (2009-04-01), Mammen et al.
patent: 7524962 (2009-04-01), Mammen et al.
patent: 7550595 (2009-06-01), Mammen et al.
patent: 7560469 (2009-07-01), Mammen et al.
patent: 7569588 (2009-08-01), Mammen et al.
patent: 7585879 (2009-09-01), Mammen et al.
patent: 7629336 (2009-12-01), Ji et al.
patent: 7632847 (2009-12-01), Mu et al.
patent: 7642355 (2010-01-01), Mu et al.
patent: 7659403 (2010-02-01), Mu et al.
patent: 7683173 (2010-03-01), Ji et al.
patent: 7687519 (2010-03-01), Mu et al.
patent: 7700777 (2010-04-01), Axt et al.
patent: 7728144 (2010-06-01), Ji et al.
patent: 2003/0018019 (2003-01-01), Meade et al.
patent: 2004/0209860 (2004-10-01), Mammen et al.
patent: 2004/0209915 (2004-10-01), Mammen et al.
patent: 2007/0112027 (2007-05-01), Axt et al.
patent: 2007/0293461 (2007-12-01), Mammen et al.
patent: 2008/0071088 (2008-03-01), Mammen et al.
patent: 2009/0018165 (2009-01-01), Mammen et al.
patent: 2009/0082397 (2009-03-01), Mammen et al.
patent: 2009/0088453 (2009-04-01), Mammen et al.
patent: 2009/0226379 (2009-09-01), Mammen et al.
patent: 0 747 355 (1996-12-01), None
patent: WO 95/06635 (1995-03-01), None
patent: WO 99/64043 (1999-12-01), None
patent: WO 01/42212 (2001-06-01), None
patent: WO 02/051841 (2002-07-01), None
patent: WO 2004/012684 (2004-02-01), None
Broadley et al., “Muscarinic Receptor Agonists and Antagonists”, Molecules, 6, pp. 142-193 (2001).
Eglen et al., “Muscarinic Receptor Subtypes:Pharmacology and Therapeutic Potential”, DN&P, 10(8), pp. 462-469 (1997).
Naito et al., “Selective Muscarinic Antagonist. II.1)Synthesis and Antimuscarinic Properties of Biphenylylcarbamate Derivatives”, Chem. Pharm. Bull. , vol. 46, No. 8, pp. 1286-1294 (1998).
Zlotos et al., “Muscarinic receptor agonists and antagonists”, Exp. Opin. Ther. Patents, 9(8), pp. 1029-1053 (1999).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Biphenyl compounds useful as muscarinic receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biphenyl compounds useful as muscarinic receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl compounds useful as muscarinic receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4254916

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.